CN106248817A - 一种金银花质量评价方法 - Google Patents
一种金银花质量评价方法 Download PDFInfo
- Publication number
- CN106248817A CN106248817A CN201610543909.0A CN201610543909A CN106248817A CN 106248817 A CN106248817 A CN 106248817A CN 201610543909 A CN201610543909 A CN 201610543909A CN 106248817 A CN106248817 A CN 106248817A
- Authority
- CN
- China
- Prior art keywords
- flos lonicerae
- quality
- evaluation methodology
- kinds
- iridoid glycoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000628997 Flos Species 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 44
- 238000011156 evaluation Methods 0.000 title claims abstract description 23
- 229930182489 iridoid glycoside Natural products 0.000 claims abstract description 33
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 claims abstract description 27
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 claims abstract description 26
- 239000000470 constituent Substances 0.000 claims abstract description 26
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 claims abstract description 24
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 claims abstract description 24
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims abstract description 17
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims abstract description 17
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims abstract description 17
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims abstract description 17
- 229940074393 chlorogenic acid Drugs 0.000 claims abstract description 17
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims abstract description 17
- 235000001368 chlorogenic acid Nutrition 0.000 claims abstract description 17
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims abstract description 17
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 claims abstract description 13
- WJHSRFQBVYHKKL-UHFFFAOYSA-N Oroboside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(C=3C=C(O)C(O)=CC=3)=COC2=C1 WJHSRFQBVYHKKL-UHFFFAOYSA-N 0.000 claims abstract description 13
- VSJGJMKGNMDJCI-ZASXJUAOSA-N Sweroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](CCOC2=O)C2=CO1 VSJGJMKGNMDJCI-ZASXJUAOSA-N 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 13
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 claims abstract description 13
- VSJGJMKGNMDJCI-QXSNVGMTSA-N sweroside Natural products OC[C@H]1O[C@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O VSJGJMKGNMDJCI-QXSNVGMTSA-N 0.000 claims abstract description 13
- 230000003647 oxidation Effects 0.000 claims abstract description 12
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 12
- CWQIQFQIBVGOHB-UHFFFAOYSA-N Secologanin dimethyl acetal Natural products COC(OC)C1C(C=C)C(OC2OC(CO)C(O)C(O)C2O)OC=C1C(=O)OC CWQIQFQIBVGOHB-UHFFFAOYSA-N 0.000 claims abstract description 9
- HUVIXLWRQSMCLN-PXRCHJMLSA-N methyl (2s,3r,4s)-4-(2,2-dimethoxyethyl)-3-ethenyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2h-pyran-5-carboxylate Chemical compound O1C=C(C(=O)OC)[C@@H](CC(OC)OC)[C@@H](C=C)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HUVIXLWRQSMCLN-PXRCHJMLSA-N 0.000 claims abstract description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 229930182470 glycoside Natural products 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- -1 Methyl acetal Chemical class 0.000 claims description 6
- 150000002338 glycosides Chemical class 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 150000008145 iridoid glycosides Chemical class 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000013558 reference substance Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- CSKKDSFETGLMSB-FUJZYWHJSA-N Secologanin Natural products C=C[C@@H]1[C@H](CC=O)C(C(=O)OC)=CO[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CSKKDSFETGLMSB-FUJZYWHJSA-N 0.000 claims description 3
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- 238000010812 external standard method Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 238000004445 quantitative analysis Methods 0.000 claims description 3
- 238000000611 regression analysis Methods 0.000 claims description 3
- 239000012086 standard solution Substances 0.000 claims description 3
- 235000007586 terpenes Nutrition 0.000 claims description 3
- CSKKDSFETGLMSB-NRZPKYKESA-N (-)-secologanin Chemical compound C=C[C@@H]1[C@H](CC=O)C(C(=O)OC)=CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CSKKDSFETGLMSB-NRZPKYKESA-N 0.000 claims description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 238000010828 elution Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 241001128140 Reseda Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 10
- 241001570521 Lonicera periclymenum Species 0.000 abstract description 5
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 4
- 241000245240 Lonicera Species 0.000 abstract description 3
- 238000003908 quality control method Methods 0.000 abstract description 3
- 238000002414 normal-phase solid-phase extraction Methods 0.000 abstract description 2
- LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 abstract 1
- 238000000275 quality assurance Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000013441 quality evaluation Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610543909.0A CN106248817B (zh) | 2016-07-11 | 2016-07-11 | 一种金银花质量评价方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610543909.0A CN106248817B (zh) | 2016-07-11 | 2016-07-11 | 一种金银花质量评价方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106248817A true CN106248817A (zh) | 2016-12-21 |
CN106248817B CN106248817B (zh) | 2018-10-26 |
Family
ID=57613781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610543909.0A Active CN106248817B (zh) | 2016-07-11 | 2016-07-11 | 一种金银花质量评价方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106248817B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106770829A (zh) * | 2016-12-26 | 2017-05-31 | 山东省分析测试中心 | 一种测定金银花大鼠血清代谢产物的方法 |
CN109030666A (zh) * | 2018-10-09 | 2018-12-18 | 山东中医药大学 | 利用高效液相色谱鉴别金银花和山银花的方法 |
CN109212082A (zh) * | 2018-10-10 | 2019-01-15 | 桂林三金药业股份有限公司 | 一种复方罗汉果清肺制剂的含量检测方法 |
CN109730205A (zh) * | 2019-01-31 | 2019-05-10 | 宜春市茂盛饲料有限公司 | 一种具有抗病和催乳功能的天然母猪饲料 |
CN113759021A (zh) * | 2021-03-11 | 2021-12-07 | 北京康仁堂药业有限公司 | 一种评价金银花中物质量值传递规律的方法及筛选方法 |
-
2016
- 2016-07-11 CN CN201610543909.0A patent/CN106248817B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106770829A (zh) * | 2016-12-26 | 2017-05-31 | 山东省分析测试中心 | 一种测定金银花大鼠血清代谢产物的方法 |
CN109030666A (zh) * | 2018-10-09 | 2018-12-18 | 山东中医药大学 | 利用高效液相色谱鉴别金银花和山银花的方法 |
CN109030666B (zh) * | 2018-10-09 | 2022-01-11 | 山东中医药大学 | 利用高效液相色谱鉴别金银花和山银花的方法 |
CN109212082A (zh) * | 2018-10-10 | 2019-01-15 | 桂林三金药业股份有限公司 | 一种复方罗汉果清肺制剂的含量检测方法 |
CN109212082B (zh) * | 2018-10-10 | 2021-03-02 | 桂林三金药业股份有限公司 | 一种复方罗汉果清肺制剂的含量检测方法 |
CN109730205A (zh) * | 2019-01-31 | 2019-05-10 | 宜春市茂盛饲料有限公司 | 一种具有抗病和催乳功能的天然母猪饲料 |
CN113759021A (zh) * | 2021-03-11 | 2021-12-07 | 北京康仁堂药业有限公司 | 一种评价金银花中物质量值传递规律的方法及筛选方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106248817B (zh) | 2018-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106248817A (zh) | 一种金银花质量评价方法 | |
WO2017148418A1 (zh) | 一种中药组合物的含量测定方法 | |
CN105606734B (zh) | 一种快速高分离度液相色谱检测金银花和山银花药材的方法 | |
CN103940929B (zh) | 一种治疗心脑血管疾病的中药注射液的检测方法 | |
CN101703599B (zh) | 栀子提取物的检测方法 | |
CN104020235A (zh) | 一种同时测定金银花中绿原酸和木犀草苷含量的方法 | |
CN106226415B (zh) | 一种同时测定金银花中六种环烯醚萜苷类成分的方法 | |
CN110836944A (zh) | 一种小儿解表颗粒hplc指纹图谱建立方法 | |
CN103432196A (zh) | 金钱草总黄酮及金钱草总黄酮和总多糖的制备方法 | |
CN107561192A (zh) | 一种测定板蓝根药材及其制品中r‑告依春和s‑告依春含量的方法 | |
CN107315058A (zh) | 一种检测银杏叶提取液中总银杏酸的方法 | |
CN104569195A (zh) | 一种检测含中药黄芩的牙膏中黄酮类有效成分含量的方法 | |
CN101650303A (zh) | 一种蒽酮比色法测定人参总皂苷的方法 | |
CN102464586B (zh) | 一种丹酚酸a的制备方法 | |
CN103808751A (zh) | 一种鉴别金银花药材或衍生品的方法 | |
CN108020617A (zh) | 一种测定两面针牙膏中氯化两面针碱含量的方法 | |
CN107389827A (zh) | 益母草或其复方制剂中盐酸水苏碱含量的测定方法 | |
CN105974029B (zh) | 一种同时测定连花清瘟胶囊中六种环烯醚萜苷类成分的方法 | |
CN104274727A (zh) | 清营口服液的质量检测方法 | |
CN107607653A (zh) | 测定玄参提取物指纹图谱的方法 | |
CN103058859B (zh) | 一种香椿叶中没食子酸及其甲酯的同时制备及检测方法 | |
CN101721531B (zh) | 森登四味汤有效部位及其制备方法 | |
CN110320305A (zh) | 蒲公英多种活性成分的同时检测方法 | |
CN111707749B (zh) | 一种气相色谱-质谱法测定中药液体制剂中苯酚的方法 | |
CN118112161A (zh) | 一种十六味杜鹃花丸的质量检测方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161221 Assignee: SHANDONG JINPHARM Co.,Ltd. Assignor: SHANDONG ANALYSIS AND TEST CENTER Contract record no.: X2020980009969 Denomination of invention: A quality evaluation method of honeysuckle Granted publication date: 20181026 License type: Exclusive License Record date: 20201225 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: SHANDONG JINPHARM CO.,LTD. Assignor: SHANDONG ANALYSIS AND TEST CENTER Contract record no.: X2020980009969 Date of cancellation: 20240325 |
|
EC01 | Cancellation of recordation of patent licensing contract |